PipelinePharma Logo
PipelinePharma Logo
Marketplace
Sign in Get started

Generics

Innovative Products found!

Biosimilars

Medical devices

Nutraceuticals

Filters

Pp-099 manufacturers

Filters

1 products found

pp-099

Tablets

Dossier type
US CTD
Dossier status
Under development
Country of origin
United States
Comments
Indication: Relapsed/refractory chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and other B‑cell malignancies in adults with prior lines of therapy Clinical stage: Clinical development — ongoing Phase 1/2 global studies with plans for Phase 3 initiation Modality: Small molecule proteolysis targeting chimera (PROTAC/CDAC) Mechanism / Target: Bruton's tyrosine kinase (BTK) targeting via induced protein degradation to overcome resistance mechanisms to BTK inhibitors Route / form: Oral administration (tablet/capsule formulation in development) Differentiation: First‑in‑class oral BTK degrader designed to degrade both wild‑type and mutant forms of BTK with potential to address resistance to conventional BTK inhibitors and treat multiple B‑cell malignancy subtypes
Manufacturer #38929

Clinical-stage biotech company developing targeted therapies for B-cell malignancies. Focuses on next-generation BTK degraders to overcome resistance to existing inhibitors. Strategy emphasizes global clinical trials and potential commercialization partnerships.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.